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also include cinnamycin B, duramycin, duramycin B, 
and duramycin C made by other actinomycetes [12, 17, 
20]. It is a potent antibiotic that is active against a broad 
range of Gram-positive bacteria and possesses an unusual 
mechanism of action, binding to the membrane amino 
phospholipid phosphatidylethanolamine (PE; Fig. 1c), a 
mechanism that is unique to the cinnamycin family of lan-
tibiotics [10]. The ability of these compounds to bind to 
PE has led to the use of duramycin to investigate the func-
tion and localisation of the amino phospholipid in cell 
membranes, and to their potential application as diagnos-
tic or therapeutic agents [15, 22]. PE is a major membrane 
lipid in streptomycetes [8], leading us to wonder how S. 
cinnamoneus protects itself from this potent compound at 
the onset of cinnamycin biosynthesis which commences 
upon entry into stationary phase in liquid culture. In ear-
lier work, we cloned the cinnamycin biosynthetic gene 
cluster (cin) and expressed it heterologously in Streptomy-
ces lividans [20]. Likely, functions were assigned to many 
of the genes in the cluster by bioinformatic analysis. Thus, 
cinA was proposed to encode the cinnamycin precursor 
peptide, cinM the lanthionine synthetase responsible for 
the introduction of the lanthionine and methyl-lanthionine 
bridges, cinX the hydroxylase required for modification 
of residue D15, cinTH an ABC transporter involved in the 
export of the cinnamycin, cinKR a two-component regula-
tory system of unknown function, and cinR1 the activa-
tor of the putative operon encoding the cinnamycin bio-
synthetic machinery. Some of these functions have since 
been confirmed experimentally [14]. Here, we describe 
the results of a comprehensive analysis of the cinnamy-
cin biosynthetic gene cluster in S. cinnamoneus that has 
unveiled a novel mechanism of immunity that exerts a 
controlling influence on whether cinnamycin production 
occurs or not.
Abstract Streptomyces cinnamoneus DSM 40646 pro-
duces the Class II lantibiotic cinnamycin which possesses 
an unusual mechanism of action, binding to the membrane 
lipid phosphatidylethanolamine (PE) to elicit its antimicro-
bial activity. A comprehensive analysis of the cinnamycin 
biosynthetic gene cluster has unveiled a novel mechanism 
of immunity in which the producing organism methylates 
its entire complement of PE prior to the onset of cinnamy-
cin production. Deletion of the PE methyl transferase gene 
cinorf10, or the two-component regulatory system (cinKR) 
that controls its expression, leads not only to sensitivity to 
the closely related lantibiotic duramycin, but also abolishes 
cinnamycin production, presumably reflecting a fail-safe 
mechanism that serves to ensure that biosynthesis does not 
occur until immunity has been established.
Keywords Lantibiotic · Phosphatidylethanolamine · 
Regulation · Resistance · Induction
Introduction
Cinnamycin (Fig. 1a) is a Class II lantibiotic produced 
by Streptomyces cinnamoneus DSM 40646 (Fig. 1b) and 
belongs to the wider family of Ribosomally synthesised 
post-translationally modified Peptides (RiPPs) [2]. It is 
a member of a small group of related compounds that 
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Mutational analysis of the cin gene cluster
Previous work [20] had identified a cluster of 15 genes 
(Fig. 2a) that were potentially involved in cinnamycin bio-
synthesis. To assess their roles in production of the lantibi-
otic, null mutations were made in each of the presumptive 
protein coding sequences in S. cinnamoneus by PCR-tar-
geting [7]. While individual deletion of cinorf7AMXTHR-
Korf10R1 abolished cinnamycin production (determined 
by bioassays of culture supernatants using Bacillus subti-
lis EC1524 as indicator organism and confirmed by Matrix 
Assisted Laser Desorption Ionization Time-of-Flight 
(MALDI-ToF) mass spectrometry; data not shown), dele-
tion of cinX resulted in the production of the inactive, non-
hydroxylated form of cinnamycin (deoxycinnamycin), con-
sistent with its role as an α-ketoglutarate/iron(II)-dependent 
hydroxylase [14]. Production of cinnamycin was restored 
in each of the non-producing mutants after introduction 
of the corresponding plasmid-borne wild-type gene. Dele-
tion of cinYZorf8orf9orf11 (for cinorf11, the segment not 
overlapping cinR1 was deleted) had no effect on cinnamy-
cin biosynthesis and the reason for their presence in the cin 
cluster is not known.
Transcriptional organisation of the cin gene 
cluster and a key role for cinR1 in activating 
cinnamycin production
To determine the transcriptional organisation of the cin 
gene cluster and to ultimately gain insights into the mecha-
nisms underlying the regulation of cinnamycin production, 
nuclease S1 protection studies were carried out revealing at 
least nine transcriptional start sites (Fig. 2a), five of which 
are involved in expressing genes required for biosynthesis 
of the lantibiotic (organised in the likely the transcription 
units cinorf7AMX, cinTH, cinKR, cinorf10, and cinR1). 
cinR1, at the right end of the cin cluster, encodes a mem-
ber of the SARP family of regulatory proteins [21]; the 
binding sites for these transcriptional activators are often 
characterised by a series of hexameric nucleotide repeats 
that are separated from each other by one turn (ca. 11 nt) 
of the DNA helix with the gene proximal repeat situated 
one and a half helical turns from the −10 promoter element 
recognised by RNA polymerase. Interestingly, three such 


































Fig. 1  a Structure of cinnamycin with the unusual lysino-alanine 
bridge shown in green. b Scanning electron micrograph of S. cinna-















Fig. 2  a Organisation of the cin cluster with transcriptional start 
sites identified by nuclease S1 protection studies shown by black 
arrows above the gene cluster together with the presumed extent of 
the resulting transcripts; the location of the transcriptional attenu-
ator between cinA and cinM is shown by a hairpin loop. The gene 
(cinA) encoding the precursor peptide is shown in light green, genes 
(cinorf7MX) involved in its modification in red, those involved in 
immunity (cinKRorf10) in pink, those in transport (cinTH) in dark 
green, and the likely transcriptional activator of the cinorf7AMX 
operon, cinR1, in blue. b Promoter region of cinorf7. Nucleotides 
(TC) at the 5′ end of the likely cinorf7AMX transcript identified by 
nuclease S1 protection studies are shown in pink, the putative −10 
RNA polymerase recognition sequence (TAGTGT) in black, and the 
three hexameric repeats in red
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start site (Fig. 2b). Together with the 1800-fold reduction 
(determined by qRTPCR; data not shown) in the level of 
transcription of cinorf7 upon deletion of cinR1, this sug-
gests that CinR1 is the direct transcriptional activator of 
the likely cinorf7AMX biosynthetic operon. Previously, 
we had noted the presence of an inverted repeat sequence 
located between cinA and cinM [20]; nuclease S1 protec-
tion studies revealed that this sequence, as we had specu-
lated, functions as a transcriptional attenuator, presumably 
ensuring an appropriate stoichiometry of the precursor pep-
tide CinA and the biosynthetic enzymes CinM (lanthionine 
synthetase) and CinX. While Cinorf7 has been shown to be 
required for formation of the lysino-alanine bridge [14], 
no enzymatic function for the protein has been identified; 
given that it is likely to be produced in similar quantities 
to the precursor peptide, it is conceivable that it performs 
a chaperone-like role in the formation of this unusual post-
translational modification.
cinorf10 encodes a PE monomethyltransferase
BlastP analysis of Cinorf10 suggested that it might pos-
sess PE methyltransferase (PEMT) activity. To address this 
possibility, the cinorf10 coding sequence was amplified 
by PCR from S. cinnamoneus genomic DNA, cloned into 
the pET21a expression vector (Novagen), and introduced 
into Escherichia coli BL21 (DE3). Thin layer chromatog-
raphy (TLC) analysis of lipid extracts from the induced 
cells revealed an additional spot with a similar mobility to 
monomethylphosphatidylethanolamine (MMPE) observed 
in lipid extracts of E. coli cells expressing the function-
ally characterised pmtA genes of either Bradyrhizobium 
japonicum [13] or Sinorhizobium meliloti [3] (Fig. 3a). The 
bradyrhizobial pmtA produces predominantly MMPE and 
a smaller amount of dimethyl phosphatidylethanolamine 
(DMPE) when expressed in E. coli, while cells express-















































































































































































Fig. 3  cinorf10 encodes PEMT activity. a cinorf10 coding sequence 
was amplified by PCR from S. cinnamoneus genomic DNA, cloned 
into the isopropyl β-d-1-thiogalactopyranoside (IPTG)-inducible 
expression vector pET21a, and introduced into E. coli BL21 (DE3) 
by transformation. Duplicate cultures were grown in LB liquid 
medium and one induced by the addition of 0.4 mM ITPG; lipids 
were extracted 2 h later and subjected to one-dimensional TLC with 
(propan-1-ol)-propionic acid-chloroform-water (3:2:2:1) and the 
plates developed with Dittmer–Lester Reagent. Additional controls 
included E. coli cultures expressing the pmtA genes from S. meliloti 
or B. japonicum. The arrow indicates the direction of chromatog-
raphy. b In E. coli, PE consists of a mixture of molecules with dif-
ferent acyl chains [1]. The figure shows super-imposed segments of 
the [M + H]+ mass spectra obtained with lipids isolated from E. coli 
BL21 (DE3) containing either pET21a (blue) or pET21a-cinorf10 
(red) after induction with IPTG. Note the efficient conversion of the 
presumed PE C36:2 (m/z [M + H]+ = 744.5), which is a recognised 
species in E. coli [16], to the likely methylated form with a mass of 
758.5 Da. The identities of the peaks at m/z [M + H]+ = 742.5 and 
[M + H]+ = 756.5 Da do not correspond to previously identified PE 
species (note that the height of the peak with m/z [M + H]+ = 744.5 
Da is slightly larger than the second isotope peak of the m/z 
[M + H]+ = 724.5 species indicating that it is a distinct entity). c 
cinorf10 and B. japonicum pmtA were cloned downstream of the con-
stitutive ermE* promoter in the integrative vector pIJ10257 in E. coli 
and the resulting plasmids, as well as the vector control, introduced 
into S. lividans 1326 by conjugation. The cultures were grown for 
24 h in TSB liquid medium, lipids extracted, and subjected to TLC 
analysis as described in a
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trimethyl phosphatidylethanolamine (TMPE), more com-
monly known as phosphatidylcholine (PC), although some 
mono- and dimethylated phosphatidylethanolamine could 
also be detected. Further evidence that the novel lipid 
spot observed in E. coli cultures expressing cinorf10 did, 
indeed, contain MMPE was obtained by mass spectrometry 
(Fig. 3b).
Expression of cinorf10 in S. lividans results 
in MMPE accumulation and confers resistance 
to duramycin
The cinorf10 coding sequence was next cloned into the 
integrative Streptomyces vector pIJ10257 [9] under the 
control of the constitutive ermE* promoter and introduced 
into S. lividans 1326 by conjugation. TLC analysis of lipid 
extracts of the cinorf10-containing strain again revealed 
an additional lipid spot, the mobility of which was again 
consistent with MMPE (Fig. 3c). This additional lipid spot 
was not detected in a strain containing only the pIJ10257 
vector, but a spot of similar mobility was observed in 
extracts from the strain expressing the bradyrhizobial 
pmtA.
To determine if the accumulation of MMPE could 
confer resistance to cinnamycin in S. lividans, the strain 
expressing cinorf10 was challenged with the closely related 
commercially available duramycin. Duramycin differs from 
cinnamycin by a single amino acid substitution (R2K), 
but shares an identical mode of action [11]. Expression of 
cinorf10 in the heterologous host appeared to confer com-
plete resistance to the lantibiotic (Fig. 4a).










WT                           ∆cinorf10                            ∆cinK ∆cinRb
Fig. 4  a Expression of cinorf10 in S. lividans confers immunity to 
duramycin. Confluent lawns of spores of S. lividans 1326 and the 
strain containing pIJ10257-cinorf10 were spread onto R2 agar plates, 
and assay disks containing varying amounts of duramycin were 
applied to the plate. b Top Deletion of cinorf10, cinK, or cinR in 
S. cinnamoneus results in sensitivity to duramycin. See a for assay 
details. Bottom Deletion of cinorf10, cinK, or cinR in S. cinnamoneus 
results in loss of cinnamycin production. Streaks of each of the S. cin-
namoneus strains were overlaid with soft nutrient agar containing B. 
subtilis as indicator
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Deletion of cinL, cinR, or cinK in S. cinnamoneus 
results in sensitivity to duramycin as well 
as abolishing cinnamycin production
The mutational analysis described earlier had shown that 
deletion of cinorf10, cinR, or cinK in S. cinnamoneus 
resulted in loss of cinnamycin production. To assess the 
effect of these deletions on immunity to cinnamycin, bio-
assays were carried out revealing that each of the mutants 
had become sensitive to duramycin (Fig. 4b), consistent 
with a role for cinKR in regulating cinorf10 expression 
and potentially that establishment of immunity is a pre-
requisite for biosynthesis. Both resistance to duramycin 
and notably cinnamycin production was restored to each of 
the deletion strains following the introduction of pIJ10257 
with cinorf10 expressed from the ermE* promoter (data not 
shown); the ability of constitutively expressed cinorf10 to 
suppress the non-producing phenotype of the mutants indi-
cates that the only essential role for CinKR in cinnamycin 
biosynthesis is to regulate cinorf10 expression.
Expression of PEMT activity is induced 
by sub‑inhibitory concentrations of duramycin
To confirm the roles of cinR, cinK, and cinorf10 in MMPE 
accumulation and duramycin resistance, segments of the 
cin cluster containing all three genes or just cinorf10 (with 
its own promoter) were introduced into S. lividans 1326 
using the integrative vector pMS81 [6]. The ability of the 
plasmids to confer resistance to duramycin and to promote 
the formation of MMPE was then assessed. While the strain 
containing cinorf10 remained sensitive to duramycin, the 
derivative containing all three genes appeared completely 
resistant (Fig. 5a), consistent with a role for cinKR in regu-
lating the expression of cinorf10.
Analysis of lipid extracts of the duramycin resistant 
strains grown in liquid culture in the absence of the lanti-
biotic failed to reveal the presence of MMPE, although PE 
could be readily detected (Fig. 5b). However, addition of 
sub-inhibitory concentrations of duramycin to the cultures 
led to MMPE accumulation consistent with an induc-
ible immunity mechanism. Comparable levels of induction 
were observed over a wide range (0.01–1 µg/ml) of sub-
inhibitory concentrations of duramycin (Fig. 6a).
In an attempt to address whether induction might reflect 
a direct interaction of duramycin with CinK, rather than 
membrane stress sensed by the sensor kinase, cultures were 
also treated with a variant of cinnamycin (P9Q) that lacks 
antimicrobial activity and that is thought not to bind to PE. 
In cinnamycin, P9 contributes to the PE-binding pocket and 
may interact directly with the ethanolamine head group 
of the phospholipid [10, 19]. Replacement of P9 with a Q 
(glutamine) residue containing a bulky side group would 
likely interfere with the insertion of the glycerophosphoe-
thanolamine head group into its binding pocket. The abil-
ity of the variant to induce PEMT activity (Fig. 6a) sug-
gests that induction is not a consequence of membrane 
stress. Moreover, since immunity to cinnamycin appears to 
be a pre-requisite for production, the ability of the strain 
to produce deoxycinnamycin, which lacks antibiotic activ-
ity, after deletion of cinX is again consistent with specific 
induction by the lantibiotic, rather than a response to mem-
brane perturbation.
When cultures were treated with daptomycin, a cyclic 
lipopeptide antibiotic produced by Streptomyces roseospo-
rus and whose lipophilic tail is believed to insert into the 
bacterial cell membrane causing rapid membrane depolari-
zation and potassium ion efflux, and thus membrane stress 
[18], at concentrations that caused a fourfold reduction in 
growth rate and biomass accumulation, there was no induc-
tion of PEMT activity (Fig. 6b), again consistent with a 
direct role for the lantibiotic independent of its antimicro-
bial activity in inducing immunity.
Expression of PEMT activity occurs in a 
growth phase‑dependent manner and precedes 
cinnamycin production
The results described thus far suggest that expression of 
cinorf10 and establishment of immunity to cinnamycin 
might be a pre-requisite for cinnamycin production. To 
investigate this relationship further, S. lividans containing 
the entire cin cluster present in pIJ10109 [20] was grown 
in liquid culture, and the methylation status of PE and cin-
namycin production monitored throughout growth (Fig. 7). 
MMPE was first apparent in late exponential growth phase 
(around 16 h after inoculation) and increased in abun-
dance relative to PE during transition phase (20 and 22 h). 
By 24 h (stationary phase), all of the PE appeared to be 
in the methylated form, and it was at this point that cin-
namycin could first be detected in the culture supernatant 
by MALDI-ToF mass spectrometry. We suggested above 
that cinnamycin itself might induce expression of cinorf10, 
and that establishment of immunity was necessary for bio-
synthesis to occur. Consistent with this hypothesis, deletion 
of cinA from the heterologous gene cluster in S. lividans 
resulted in loss of PEMT activity as well as the expected 
abolition of cinnamycin production; PEMT activity was 
restored by the exogenous addition of sub-inhibitory con-
centrations of duramycin (Fig. 8).
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Deletion of cinorf10 abolishes cinnamycin 
production but has no effect on cinorf7 and cinM 
transcription
Since deletion of cinorf10 abolished cinnamycin produc-
tion in S. cinnamoneus, we set out to assess the effect 
of the mutation on transcription of cinorf7 and thus the 
cinorf7AMX operon. The wild-type strain was first cul-
tured in TSB liquid medium, RNA isolated at different 
times during growth and subjected to qRTPCR (real-time 
quantitative reverse transcription PCR) analysis (Fig. 9). 
Cinnamycin production was first detected (by MALDI-
ToF mass spectrometry) in stationary phase after 16 h of 
incubation (Fig. 9a), corresponding to maximal levels of 
transcript abundance of cinMXTHR1 which subsequently 
declined (Fig. 9b). The levels of the cinorf7A transcripts, 
which were markedly higher than those of cinMX, presum-
ably reflecting the presence of the transcriptional attenua-
tor located between cinA and cinM, remained close to their 
maximal levels beyond 16 h of incubation. Transcription 
of cinKR did not increase upon entry into stationary phase, 
but declined somewhat, consistent with a role in sensing 
exogenous cinnamycin. Interestingly, transcript levels for 
cinorf10 peaked after 14 h, before those of the other cin 
genes, and before cinnamycin could be detected in the cul-
ture supernatant, again consistent with a role in establish-
ing immunity to cinnamycin prior to the onset of detect-
able production. We next assessed the effect of mutations 
in cinAorf10R1 on cinorf7 and cinM transcription in RNA 
samples isolated after 8 and 16 h of incubation (Fig. 9d; 
since the data acquired for cinorf7 and cinM are essentially 








































































Fig. 5  a cinKR are required for expression of cinorf10 from its 
own promoter in S. lividans. The segment of the cin cluster cloned 
in pMS81 is shown below the gene map. Bioassays were carried out 
as in Fig. 4a. b PEMT activity is dependent on cinKR and requires 
induction with duramycin. The S. lividans derivatives described in a, 
together with the vector (pMS81) control, were grown in duplicate in 
TSB liquid medium; after 8 h, a sub-inhibitory concentration (1 µg/
ml) of duramycin was added to one of the duplicates and all cultures 
grown for an additional 16 h. S. lividans containing pIJ10109 (carry-
ing the entre cin cluster) was grown in TSB for 24 h as a further con-
trol. Lipids were then extracted and subjected to TLC analysis
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operon, only the results for cinorf7 are presented). Activa-
tion of transcription of cinorf7 and cinM was essentially 
abolished in the cinR1 mutant, consistent with the latter’s 
proposed role as the direct transcriptional activator of the 
cinorf7AMX operon. Deletion of cinA caused a marked 
reduction in the levels of induction, but did not completely 
abolish it, commensurate with a role for cinnamycin in 
promoting maximal levels of cinorf7AMX transcription. 
Surprisingly, since the mutant fails to produce the lantibi-












































































































































Fig. 6  a PEMT activity can be induced with inactive cinnamycin 
P9Q. S. lividans 1326 cultures containing cinKRorf10 cloned in the 
integrative pMS81 vector were grown in TSB liquid medium for 24 h 
after addition of various amounts of duramycin or the inactive cin-
namycin variant P9Q at 8 h. Lipids were then extracted and subjected 
to TLC analysis. b PEMT activity is not induced by membrane active 
daptomycin. Quadruplicate cultures of the same strain were grown 
in TSB liquid medium; after 8 h, a sub-inhibitory concentration of 
duramycin was added to one culture, the inactive cinnamycin P9Q to 
another, and daptomycin at a concentration that resulted in a fourfold 
reduction in growth rate and biomass accumulation to a third; nothing 
was added to the fourth. The cultures were grown for a total of 24 h, 
harvested, and lipids analysed by TLC. In both a and b, S. lividans 
containing pIJ10109 was used as a control for chromatography







Fig. 7  Growth phase-dependent methylation of PE in S. lividans con-
taining the cloned cin cluster. TLC analysis of extracted membrane 
lipids of S. lividans 1326 containing pIJ10109. Exponential and sta-
tionary phases of growth are indicated, together with the appearance 






























Fig. 8  cinA is required for PEMT activity. S. lividans 1326 con-
taining pIJ10109 and duplicate cultures of a derivative from which 
cinA had been deleted (in-frame deletion) were grown in TSB liquid 
medium. Duramycin (1 µg/ml) was added to one of the ΔcinA cul-
tures after 8 h of incubation and all of the cultures harvested after a 
total of 24 h. Lipids were extracted and analysed by TLC
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The lysino‑alanine bridge of cinnamycin  
is required for antibacterial activity
Our earlier deletion analysis had shown that cinorf7 is 
essential for cinnamycin biosynthesis in S. cinnamoneus. 
More recently, co-expression studies in E. coli have shown 
that the same gene was required for lysino-alanine bridge 
formation and that the latter was required for antibacterial 
activity [14]. In a complementary approach, the substrate 
flexibility of CinM and CinX was exploited using an in vivo 
expression system developed by Jesus Cortes (Novacta 
Biosystems) to generate cinnamycin variants in S. cinna-
moneus in which S6 or K19 were replaced with A. Produc-
tion of both variants (S6A, 2042 Da; K19A, 1983 Da) was 
readily confirmed by MALDI-ToF mass spectrometry, but 
both failed to inhibit B. subtilis in bioassays, confirming the 
previous E. coli expression studies.
Conclusions
The results described here allow us to present a model 
for the regulation of cinnamycin biosynthesis (Fig. 10). 
We propose that activation of expression of the cin clus-
ter is initiated by nutrient limitation that results in a low 
level of transcription of cinR1 (1). This results in a low 
level of expression of the proposed cinorf7AMX operon 
and the production of a small amount of cinnamycin that 
is exported from the cell by CinTH (2). Cinnamycin then 
interacts with the membrane-associated sensor kinase CinK 
which results in phosphorylation of CinR and activation of 
transcription of cinorf10 encoding the PEMT (3). CinR-P 
may also further activate transcription of cinR1 (transcrip-
tion of cinR1 in a cinR mutant is reduced tenfold compared 
with the wild-type strain, data not shown) (4), resulting in 
higher levels of transcription of the cinorf7AMX operon 
(4). In the meantime, Cinorf10 proceeds to methylate PE 
in the membrane (5) and only when all of the PE has been 
modified does high-level production of cinnamycin occur 
(6). Intriguingly, while deletion of cinorf10 abolishes cin-
namycin production, it appears to have no effect on the 
level of transcription of the cinorf7AMX operon, implying 
the existence of post-transcriptional regulatory feedback 
mechanism that functions to ensure that cinnamycin pro-
duction only occurs once immunity to the lantibiotic has 
been established. The existence of an apparent fail-safe 
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Fig. 9  qRTPCR analysis of cin gene expression in S. cinnamoneus. 
a Growth curve of S. cinnamoneus with biomass estimated by meas-
uring total protein content. b qRTPCR analysis of cinorf7AMXTHR1 
transcription during growth. c qRTPCR analysis of cinKRorf10 tran-
scription during growth. d qRTPCR analysis of cinorf7 transcription 
after 8 h and 16 h of incubation in the wild-type strain and individual 
cinAorf10R1 mutants. The results shown are the averages obtained 
from triplicate cultures
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mechanism such as this that presumably serves to prevent 
the strain from deleterious antibiotic production before the 
establishment of immunity was also observed in micro-
bisporicin biosynthesis in Microbispora corallina, where 
deletion of an apparent immunity transporter also abolished 
lantibiotic production [4, 5]. In the latter case, microbispor-
icin was shown to be able to induce its own synthesis; it 
will be interesting to determine whether cinnamycin pos-
sesses the same property, or alternatively that the immu-
nity mechanism that we have described functions only to 
protect S. cinnamoneus from cinnamycin produced either 
by itself or other members of the microbial community in 
which it exists in nature.
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